
Ozempic’s Unknowns
06/09/24 • 36 min
2 Listeners
Nearly half of Americans say they’re willing to pay for weight-loss drugs. But what are the downsides to these so-called “miracle drugs”?
Johann Hari is the author of the book, “Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight Loss Drugs.” Ricky Mulvey caught up with Hari for a conversation about:
- The medical magic that makes GLPs so effective
- Whether online pharmacies can responsibly prescribe these drugs
- Why there’s a much larger market for these in the US than in other parts of the world
To see where you can get a copy of “Magic Pill,” head to: www.magicpillbook.com
Host: Ricky Mulvey
Guest: Johann Hari
Producer: Mary Long
Engineer: Tim Sparks
Companies discussed: NVO, LLY, ZM
Learn more about your ad choices. Visit megaphone.fm/adchoices
Nearly half of Americans say they’re willing to pay for weight-loss drugs. But what are the downsides to these so-called “miracle drugs”?
Johann Hari is the author of the book, “Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight Loss Drugs.” Ricky Mulvey caught up with Hari for a conversation about:
- The medical magic that makes GLPs so effective
- Whether online pharmacies can responsibly prescribe these drugs
- Why there’s a much larger market for these in the US than in other parts of the world
To see where you can get a copy of “Magic Pill,” head to: www.magicpillbook.com
Host: Ricky Mulvey
Guest: Johann Hari
Producer: Mary Long
Engineer: Tim Sparks
Companies discussed: NVO, LLY, ZM
Learn more about your ad choices. Visit megaphone.fm/adchoices
Previous Episode

Is Multifamily Overbuilt?
Last year, 440,000 new apartments went on the market – a 36-year high. This year, even more new builds are coming. That’s good news for renters, but perhaps less good for developers. What about REIT investors?
Matt Argersinger and Ricky Mulvey discuss the state of the multifamily market and why REITs (of any stripe!) aren’t out for the count quite yet.
Host: Ricky Mulvey
Guest: Matt Argersinger
Producer: Mary Long
Engineer: Dan Boyd
Epic Bundle discount link: www.fool.com/epic
Companies discussed: MAA, PLD, DLR, SPG
Learn more about your ad choices. Visit megaphone.fm/adchoices
Next Episode

We Can Fix You, Southwest
Elliott Management amps up the activist activity, and puts Southwest’s leadership and board on notice.
(00:21) Asit Sharma and Dylan Lewis discuss:
Why Elliot Management is looking to shakeup leadership at Southwest after taking a 10%+ stake in the airline.
Nvidia’s stock split, and why this one may matter more than most.
The new names in the S&P 500 – Crowdstrike, KKR, and GoDaddy – and what they say about the state of the market.
(17:57) Are the world’s tallest buildings ego-projects or promising investment opportunities? Ricky Mulvey talks with economist and skyscraper expert Jason Barr, about the state of “supertalls” and how China’s building boom is leading to an increase in homeowners without homes.
Companies discussed: LUV, NVDA, CRWD, KKR, GDDY, RHI, CMA, ILMN
Host: Dylan Lewis
Guests: Asit Sharma, Ricky Mulvey, Jason Barr
Producer: Ricky Mulvey
Engineers: Dan Boyd
Visit our sponsor Monarch Money: Go to monarchmoney.com/FOOL for an extended 30 day free trial.
Learn more about your ad choices. Visit megaphone.fm/adchoices
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/motley-fool-money-143275/ozempics-unknowns-53800763"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to ozempic’s unknowns on goodpods" style="width: 225px" /> </a>
Copy